Barfresh Food (BRFH) traded down -4.92 % during a 24 hours period ending at 04:06 PM Central Europe on Tuesday 27th. One Barfresh Food stock can currently be bought for about USD 0.62 on popular exchanges. Current supply of Barfresh Food stocks is 16.3 mn. Barfresh Food has a current market capitalization of USD 9.9 mn and approximately USD 11.8 k worth of Barfresh Food was traded on exchanges in the last 24 hours. Since last month end, Barfresh Food has traded -30.12 % down. Simple moving average of last 200 days is at USD 2.1. The highest price of past 52 weeks was recorded at USD 3.5 on 12/16/2025. 52 weeks low was at USD 0.56 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Curvebeam Ai (CVB.AX) traded down -4.76 % and now trades at AUD 0.02. Curvebeam Ai has a market capitalisation of AUD 16.1 mn. CurveBeam AI Limited has recently filed an initial director’s interest notice with the Australian Securities Exchange. The notice discloses that Daniel A. Pryor, who was appointed on 25 October 2026, holds a significant number of ordinary shares and share rights in the company. No other notable interests or contracts have been reported in the filing. The disclosure, made in compliance with listing rule 3.19A.1, provides the market with transparency regarding the director’s holdings but does not indicate any immediate changes to the company’s financial position or strategic direction.
Bloomia (TULP) traded down -4.17 % and now trades at USD 2.3. Current market capitalisation for Bloomia is USD 11.6 mn.
Cellectar Biosciences (CLRB) traded down -0.82 % and now trades at USD 1.24. Cellectar Biosciences has a market capitalisation of USD 11.4 mn.
Defi Capital Markets (DCM) traded down -4.55 % and now trades at USD 3.58. Defi Capital Markets has a market capitalisation of USD 11.3 mn. DeFi Capital Markets, Inc. filed a registration statement on Form S‑3 on 26 October 2026, detailing an offering of up to 2.65 million shares of common stock to be issued upon conversion of newly issued convertible promissory notes. The notes were sold in three tranches to a single selling stockholder, with the final tranche pending approval of stockholders and the exchange listing authority. The company’s common stock trades on the NYSE American under the symbol “DCM.” On the same day, DeFi Capital Markets submitted a definitive proxy statement for its 2026 annual meeting, correcting a typographical error in the director nomination list. The proxy materials outline proposals for board elections, amendments to the articles of incorporation, and approval of additional shares related to the convertible notes. The filings reflect ongoing corporate restructuring, including a recent name change from Universal Safety Products, Inc. to DeFi Capital Markets, Inc., and the continuation of its transition toward a digital‑asset and financial‑technology focus.
Actuate Therapeutics (ACTU) traded up 11.16 % and now trades at USD 0.42. Current market capitalisation for Actuate Therapeutics is USD 11.4 mn. Actuate Therapeutics, Inc. has filed a formal SEC EFFECT submission confirming the effective date of its S‑1 registration statement. The filing, recorded on October 26, 2026, updates the company’s public disclosure status under the 1933 Act and notes that the document is now live. The submission confirms the company’s name, formerly Apotheca Therapeutics, and provides its current address and contact details. No additional business or financial information is disclosed in this filing.
About Barfresh Food
The Barfresh Food Group Inc. is a US-based company that specializes in the manufacture and distribution of beverages. They offer smoothies, shakes and frappes and serve their products in various establishments across the country, such as restaurants, hospitals, hotels, resorts, amusement parks and colleges. You can learn more about their offerings and services on their website, which is www.barfresh.com . The company’s stock is traded on the Nasdaq.